The maker of a promising ovarian cancer drug said, Friday, that he stopped enrolling women in a study because several patients developed gastrointestinal holes.
The maker of a promising ovarian cancer drug is white.
( z1 white :ARG1 ( z2 person :ARG0-of ( z3 make :ARG1 ( z4 drug :ARG0-of ( z5 promise ) :purpose ( z6 disease :name ( z7 name :op "ovarian" :op "cancer" ) ) ) ) ) )